These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17375556)

  • 1. Nanotechnology and pharmaceutical inhalation aerosols.
    Patel AR; Vavia PR
    Indian J Exp Biol; 2007 Feb; 45(2):166-74. PubMed ID: 17375556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical perspectives on pulmonary systemic and macromolecular delivery.
    Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for drug delivery to the lungs.
    Sung JC; Pulliam BL; Edwards DA
    Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment by inhalation of macromolecules--principles, problems, and examples.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():53-79. PubMed ID: 19218633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):595-606. PubMed ID: 17970663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Layered double hydroxide nanoparticles in gene and drug delivery.
    Ladewig K; Xu ZP; Lu GQ
    Expert Opin Drug Deliv; 2009 Sep; 6(9):907-22. PubMed ID: 19686052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment methods of inhaled aerosols: technical aspects and applications.
    Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H
    Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans.
    Hickey AJ; Garcia-Contreras L
    Crit Rev Ther Drug Carrier Syst; 2001; 18(4):387-431. PubMed ID: 11605897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of particle deposition in asymmetrical tracheobronchial model geometry.
    Farkas A; Balásházy I
    Comput Biol Med; 2008 Apr; 38(4):508-18. PubMed ID: 18336809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary drug delivery: medicines for inhalation.
    Henning A; Hein S; Schneider M; Bur M; Lehr CM
    Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
    Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
    Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nanoparticles--a current review.
    Yang W; Peters JI; Williams RO
    Int J Pharm; 2008 May; 356(1-2):239-47. PubMed ID: 18358652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches to enhance pulmonary delivery of proteins and peptides.
    Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):615-25. PubMed ID: 18204175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal evolution of nanoparticle aerosols in workplace exposure.
    Seipenbusch M; Binder A; Kasper G
    Ann Occup Hyg; 2008 Nov; 52(8):707-16. PubMed ID: 18927101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.